Click for best price
AntiObesity Drugs Antiobesity Medication Market Size, Share 2023
| Market size in 2022 |
US$ 1876.9 million
|
Forecast Market size by 2030 |
US$ 5385.2 million
|
| Growth Rate |
CAGR of 16.2% |
Number of Pages |
124 Pages |
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Drugs (Anti-obesity Medication), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Drugs (Anti-obesity Medication). This report contains market size and forecasts of Anti-Obesity Drugs (Anti-obesity Medication) in global, including the following market information:
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Anti-Obesity Drugs (Anti-obesity Medication) companies in 2022 (%)
The global Anti-Obesity Drugs (Anti-obesity Medication) market was valued at US$ 1876.9 million in 2022 and is projected to reach US$ 5385.2 million by 2030, at a CAGR of 16.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
by Drug Varieties Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-Obesity Drugs (Anti-obesity Medication) include Zafgan, Vivus, Shionogi, Sanofi, Rhythm Pharmaceuticals, Pfizer, Orexigen Therapeutics, Novo Nordisk and Norgine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Obesity Drugs (Anti-obesity Medication) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, by Type, 2022 (%)
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, by Application, 2022 (%)
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Obesity Drugs (Anti-obesity Medication) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Obesity Drugs (Anti-obesity Medication) revenues share in global market, 2022 (%)
Key companies Anti-Obesity Drugs (Anti-obesity Medication) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Obesity Drugs (Anti-obesity Medication) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Obesity Drugs (Anti-obesity Medication), market overview.
Chapter 2: Global Anti-Obesity Drugs (Anti-obesity Medication) market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Obesity Drugs (Anti-obesity Medication) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Obesity Drugs (Anti-obesity Medication) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Obesity Drugs (Anti-obesity Medication) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Obesity Drugs (Anti-obesity Medication) Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 1876.9 million
|
| Forecast Market size by 2030 |
US$ 5385.2 million
|
| Growth Rate |
CAGR of 16.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
124 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Drugs (Anti-obesity Medication) Overall Market Size
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size: 2022 VS 2030
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales: 2018-2030
3 Company Landscape
3.1 Top Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.2 Top Global Anti-Obesity Drugs (Anti-obesity Medication) Companies Ranked by Revenue
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Companies
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Companies
3.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Obesity Drugs (Anti-obesity Medication) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Drugs (Anti-obesity Medication) Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Markets, 2022 & 2030
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2023
4.2.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2024-2030
4.2.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
4.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2023
4.3.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2024-2030
4.3.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
4.4 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2022 & 2030
5.1.2 Childhood (0-6)
5.1.3 Juvenile (7-17)
5.1.4 Youth (18-40)
5.1.5 Middle Aged (41-60)
5.1.6 Elderly (Above 60)
5.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2023
5.2.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2024-2030
5.2.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
5.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2023
5.3.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2024-2030
5.3.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
5.4 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2022 & 2030
6.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2023
6.2.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2024-2030
6.2.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
6.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2023
6.3.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2024-2030
6.3.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030
6.4.2 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2030
6.4.3 US Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.4.4 Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.4.5 Mexico Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030
6.5.2 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2030
6.5.3 Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.4 France Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.5 U.K. Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.6 Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.7 Russia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.8 Nordic Countries Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.5.9 Benelux Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030
6.6.2 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2030
6.6.3 China Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.6.4 Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.6.5 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.6.6 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.6.7 India Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030
6.7.2 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2030
6.7.3 Brazil Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.7.4 Argentina Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2018-2030
6.8.3 Turkey Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.8.4 Israel Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.8.5 Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
6.8.6 UAE Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Zafgan
7.1.1 Zafgan Company Summary
7.1.2 Zafgan Business Overview
7.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.1.5 Zafgan Key News & Latest Developments
7.2 Vivus
7.2.1 Vivus Company Summary
7.2.2 Vivus Business Overview
7.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.2.5 Vivus Key News & Latest Developments
7.3 Shionogi
7.3.1 Shionogi Company Summary
7.3.2 Shionogi Business Overview
7.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.3.5 Shionogi Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Rhythm Pharmaceuticals
7.5.1 Rhythm Pharmaceuticals Company Summary
7.5.2 Rhythm Pharmaceuticals Business Overview
7.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.5.5 Rhythm Pharmaceuticals Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Company Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.7.5 Orexigen Therapeutics Key News & Latest Developments
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.8.5 Novo Nordisk Key News & Latest Developments
7.9 Norgine
7.9.1 Norgine Company Summary
7.9.2 Norgine Business Overview
7.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.9.5 Norgine Key News & Latest Developments
7.10 Nalpropion Pharmaceuticals Inc.
7.10.1 Nalpropion Pharmaceuticals Inc. Company Summary
7.10.2 Nalpropion Pharmaceuticals Inc. Business Overview
7.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.10.5 Nalpropion Pharmaceuticals Inc. Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Summary
7.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.12.5 GlaxoSmithKline Key News & Latest Developments
7.13 F.Hoffmann-La Roche
7.13.1 F.Hoffmann-La Roche Company Summary
7.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.13.5 F.Hoffmann-La Roche Key News & Latest Developments
7.14 Eisai
7.14.1 Eisai Company Summary
7.14.2 Eisai Business Overview
7.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.14.5 Eisai Key News & Latest Developments
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Company Summary
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.15.5 Boehringer Ingelheim Key News & Latest Developments
7.16 Bayer AG
7.16.1 Bayer AG Company Summary
7.16.2 Bayer AG Business Overview
7.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.16.5 Bayer AG Key News & Latest Developments
7.17 AstraZeneca
7.17.1 AstraZeneca Company Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.17.5 AstraZeneca Key News & Latest Developments
7.18 Arena Pharmaceuticals
7.18.1 Arena Pharmaceuticals Company Summary
7.18.2 Arena Pharmaceuticals Business Overview
7.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.18.5 Arena Pharmaceuticals Key News & Latest Developments
7.19 Amylin
7.19.1 Amylin Company Summary
7.19.2 Amylin Business Overview
7.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.19.5 Amylin Key News & Latest Developments
7.20 Alizyme
7.20.1 Alizyme Company Summary
7.20.2 Alizyme Business Overview
7.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2018-2023)
7.20.5 Alizyme Key News & Latest Developments
8 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, Analysis
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, 2018-2030
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Drugs (Anti-obesity Medication) Supply Chain Analysis
10.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Value Chain
10.2 Anti-Obesity Drugs (Anti-obesity Medication) Upstream Market
10.3 Anti-Obesity Drugs (Anti-obesity Medication) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Obesity Drugs (Anti-obesity Medication) in Global Market
Table 2. Top Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 9. List of Global Tier 1 Anti-Obesity Drugs (Anti-obesity Medication) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2024-2030
Table 16. By Application ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2024-2030
Table 21. By Region ? Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), 2024-2030
Table 26. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2024-2030
Table 30. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2024-2030
Table 34. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2024-2030
Table 38. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, (K Units), 2024-2030
Table 46. Zafgan Company Summary
Table 47. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 48. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Zafgan Key News & Latest Developments
Table 50. Vivus Company Summary
Table 51. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 52. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Vivus Key News & Latest Developments
Table 54. Shionogi Company Summary
Table 55. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 56. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Shionogi Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 60. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Rhythm Pharmaceuticals Company Summary
Table 63. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 64. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Rhythm Pharmaceuticals Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 68. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Orexigen Therapeutics Company Summary
Table 71. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 72. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Orexigen Therapeutics Key News & Latest Developments
Table 74. Novo Nordisk Company Summary
Table 75. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 76. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novo Nordisk Key News & Latest Developments
Table 78. Norgine Company Summary
Table 79. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 80. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Norgine Key News & Latest Developments
Table 82. Nalpropion Pharmaceuticals Inc. Company Summary
Table 83. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 84. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Nalpropion Pharmaceuticals Inc. Key News & Latest Developments
Table 86. Merck Company Summary
Table 87. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 88. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Merck Key News & Latest Developments
Table 90. GlaxoSmithKline Company Summary
Table 91. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 92. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. GlaxoSmithKline Key News & Latest Developments
Table 94. F.Hoffmann-La Roche Company Summary
Table 95. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 96. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. F.Hoffmann-La Roche Key News & Latest Developments
Table 98. Eisai Company Summary
Table 99. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 100. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Eisai Key News & Latest Developments
Table 102. Boehringer Ingelheim Company Summary
Table 103. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 104. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Boehringer Ingelheim Key News & Latest Developments
Table 106. Bayer AG Company Summary
Table 107. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 108. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Bayer AG Key News & Latest Developments
Table 110. AstraZeneca Company Summary
Table 111. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 112. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. AstraZeneca Key News & Latest Developments
Table 114. Arena Pharmaceuticals Company Summary
Table 115. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 116. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Arena Pharmaceuticals Key News & Latest Developments
Table 118. Amylin Company Summary
Table 119. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 120. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Amylin Key News & Latest Developments
Table 122. Alizyme Company Summary
Table 123. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Offerings
Table 124. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Alizyme Key News & Latest Developments
Table 126. Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Anti-Obesity Drugs (Anti-obesity Medication) Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region, 2018-2023 (K Units)
Table 129. Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region, 2024-2030 (K Units)
Table 130. Anti-Obesity Drugs (Anti-obesity Medication) Market Opportunities & Trends in Global Market
Table 131. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers in Global Market
Table 132. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints in Global Market
Table 133. Anti-Obesity Drugs (Anti-obesity Medication) Raw Materials
Table 134. Anti-Obesity Drugs (Anti-obesity Medication) Raw Materials Suppliers in Global Market
Table 135. Typical Anti-Obesity Drugs (Anti-obesity Medication) Downstream
Table 136. Anti-Obesity Drugs (Anti-obesity Medication) Downstream Clients in Global Market
Table 137. Anti-Obesity Drugs (Anti-obesity Medication) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type in 2022
Figure 2. Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application in 2022
Figure 3. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2018-2030 (US$, Mn)
Figure 7. Anti-Obesity Drugs (Anti-obesity Medication) Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2022
Figure 9. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 11. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 12. By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 15. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 16. By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 20. By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 21. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 22. By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 23. US Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 28. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 29. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 37. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 41. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 43. By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 44. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2018-2030
Figure 48. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Anti-Obesity Drugs (Anti-obesity Medication) Revenue, (US$, Mn), 2018-2030
Figure 52. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Anti-Obesity Drugs (Anti-obesity Medication) by Region, 2022 VS 2030
Figure 54. Anti-Obesity Drugs (Anti-obesity Medication) Industry Value Chain
Figure 55. Marketing Channels
